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Abstract
The purpose of this study was to investigate
the beneﬁts of a pedometer and a cognitive-
behavioural group intervention for promoting
physical activity (PA) in type 2 diabetes
patients. We recruited 41 participants and
randomized them into an intervention group
(IG) (n 5 20) and a control group (CG) (n 5
21). The intervention consisted of ﬁve sessions
within 12 weeks, a booster session after 22
weeks and a pedometer. Primary outcome was
PA assessed by accelerometer (minutes per
day) and pedometer (steps per day). Secondary
outcomes were weight, body mass index, blood
pressure, haemoglobin A1c and total choles-
terol. After 12 weeks, the IG increased with
more than 2000 steps day
21 compared with
the CG, whereas sedentary behaviour de-
creased more than 1 hour day
21 in the IG
and showed no change in the CG. There was
no intervention effect on the accelerometer-
based PA nor on health measurements. After
1 year, the increase in steps per day remained
signiﬁcant in the IG, but sedentary activity in-
creased again to baseline levels. This pilot
study showed that the combination of a 12-
week cognitive-behavioura intervention and
a pedometer has a signiﬁcant short-term im-
pact on daily steps and sedentary behaviour
but that the effects on total PA and long-term
effects were limited.
Introduction
Despite the volume of evidence supporting the
physical activity (PA) beneﬁts in diabetes manage-
ment [1], there is a dearth of interventions achieving
change in PA behaviour in type 2 diabetes patients
[2]. The majority of earlier studies investigating the
effects of PA on type 2 diabetes has incorporated
structured exercise programmes. These pro-
grammes showed favourable effects on glycaemic
control, cardiovascular ﬁtness, weight loss and hy-
pertension [3]. Nevertheless, they were expensive
and time-consuming [4], often targeting a highly
motivated selected group [5], manifesting high
dropout rates and a problematic long-term
adherence [6]. In addition, type 2 diabetes patients
are often not interested in joining such a time-
demanding programme [7].
A recently observed shift has been away from
structured programmes towards lifestyle interven-
tions, which aim at increasing PA on a self-
structured frequent basis [8]. Such programmes
offer personal ﬂexibility in scheduling and there-
fore reduce barriers such as lack of time, transport
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original work is properly cited.or high costs [9]. Lifestyle and structured pro-
grammes are both similarly effective at increasing
PA, cardiovascular ﬁtness and decreasing blood
pressure for sedentary healthy adults [8]. However,
results from a randomized control trial that com-
pared structured and lifestyle goals in a walking
programme for type 2 diabetes patients showed that
those who received lifestyle goals were more satis-
ﬁed with the intervention and self-monitored their
PA more often [10].
Only a few studies evaluated the effects of
a lifestyle-based PA intervention in type 2 diabetes
patients. Yamanouchi et al. conducted a clinical trial
for type 2 diabetes patients to evaluate the effects of
daily walking combined with diet versus diet alone.
The PA intervention group (IG) was instructed to
walk at least 10 000 steps day
1,m o n i t o r e db yap e -
dometer. After 8 weeks of intervention, the PA IG
increased their steps per day and walking was found
to be a signiﬁcant determinant of improved insulin
sensitivity. However, no long-term results are avail-
able [11]. Araiza et al. tried to determine whether the
recommendation to walk 10 000 steps day
1 would
result in increased PA. In contrast to the control
group (CG), the IG increased to 10 000 steps day
1
after 6 weeks but also in this study, no long-term
results are available [12].
Tudor-Locke et al. [13] recently developed the
First Step Program (FSP) that comprises four group
meetings, followed by a 12-week adherence phase.
The effects were analysed after 16 weeks of inter-
vention and a 24-week follow-up. Relative to the
CG, FSP participants increased their PA levels sig-
niﬁcantly after the intervention, but at follow-up,
steps per day decreased (although they remained
higher than baseline values). No signiﬁcant changes
emerged for glycaemia or cholesterol [14]. Kirk
et al. investigated the effectiveness of PA counsel-
ling in type 2 diabetes patients. PA consultations
were delivered at baseline and after 6 months, with
follow-up phone calls. After 12 months, the IG had
more favourable levels of self-reported PA, accel-
erometer counts, haemoglobin A1C (HbA1c), sys-
tolic blood pressure and cholesterol compared with
the CG [15]. The Look-Ahead trial offered an in-
tensive lifestyle intervention, including diet and PA
to type 2 diabetes patients. The IG signiﬁcantly de-
creased in weight and HbA1c after 1 year compared
with a CG [16]. Watanabe et al. developed a
4-month intervention for people with type 2 diabe-
tes. The IG received an individual-based counsel-
ling programme and a pedometer. As a result, the
IG engaged more in self-reported leisure time PA
compared with a CG, but only short-term results
were reported [17].
The need for PA counselling and lifestyle inter-
ventions has also appeared in primary care. Earlier
studies, investigating the effects of a general
practitioner-based PA intervention for type 2 diabe-
tes patients, showed mixed results. Di Loreto et al.
[18] and Christian et al. [19] showed that a general
practitioner-based intervention could increase PA.
Stovitz et al. [20] concluded that advice and the use
of a pedometer already results in more PA while-
Hillsdon et al. [21] argued that only advice without
lifestyle counselling is ineffective. Van Sluijs et al.
[22] found no effects after their general practitioner-
based PA intervention.
The studies above indicate that lifestyle-based
PA interventions show promising short-term results
with regard to both acceptability and effectiveness,
but data on long-term effectiveness and objective
PA measurements are often lacking [23]. In addi-
tion, it is not clear whether a group programme
(with cognitive-behavioural sessions on PA and
a pedometer) is necessary or whether care as usual
is sufﬁcient to obtain changes in health and health
behaviour. It seems that there is quite some variance
in the success rate of the interventions and to our
knowledge, none of these studies look into individ-
ual differences after the intervention.
This intervention links a strong theoretical com-
prehensive basis with pedometer use in order
to achieve long-term objective results on PA in type
2 diabetes patients. The main purpose of this study
is to (i) compare the effects of a cognitive-
behavioural group intervention and a pedometer
(IG) and minimum care as usual (CG) on objec-
tively measured PA behaviour and (ii) determine
whether the intervention had a sustained effect
after 1 year. The hypothesis is that PA will increase
more in the IG compared with the CG. As previous
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sample, it will also be reported how many partic-
ipants in each group changed their behaviour. Fur-
thermore, more favourable health measurements
for the IG are expected, due to their increased PA.
Materials and methods
Sample and procedure
A sampling pool of potential participants was gen-
erated through a manual search of patient ﬁles lo-
cated at the Endocrinology Department in a Belgian
hospital (Saint-Augustinus hospital in Veurne). The
inclusion criteria were as follows: (i) >6 months
diagnosis of type 2 diabetes, (ii) aged between 35
and 75 years, (iii) treated for type 2diabetes and (iv)
no physical or medical PA limitations.
Of the total amount of 645 patients diagnosed
with type 2 diabetes, a pool of 164 individuals
was identiﬁed as eligible to participate according
to the inclusion criteria. Fifty-one individuals
responded positively to an invitation letter; 10 of
them did not start the study (two persons had ortho-
paedic problems and eight persons found transpor-
tation to and participation in ﬁve group sessions too
demanding). Finally 41 persons were included in
the study (response rate = 25%). All of them signed
an informed consent form and were assigned via
stratiﬁed (gender and age) randomization to either
the CG [n = 21 (6 women and 15 men, 61.3 years)]
or the IG [n = 20 (7 women and 13 men, 61.3
years)]. Sealed envelopes were used and group al-
location was concealed until the point of allocation.
The Medical Ethic Committee of the University
Hospital approved the study.
The CG received their usual care from their en-
docrinologist and received one single-group educa-
tion on the effects of PA on diabetes care. The IG
was offered a cognitive-behavioural group pro-
gramme combined with a pedometer, which lasted
for 12 weeks. All sessions took place at the Endo-
crinology Department. The intervention was given
by two coaches, both possessing a Masters degree,
one in Physical Education and Movement Sciences
and another in Clinical Psychology.
Design and evaluation instruments
There were three assessment time points spread over
a period of 12 months: baseline (T0), after the 12
weeks intervention (T1) and a follow-up 1 year after
baseline (T2) (see Fig. 1). Assessments were the
same for the IG and CG. At each time point, partic-
ipants were contacted by telephone and an appoint-
ment was scheduled to complete measurements in
their home. The week following the home visit, par-
ticipants of both groups were asked to wear the PA
monitors and to go to the hospital laboratory for
blood samples.
Physical activity
The pedometer (Yamax DigiWalker SW200) and the
accelerometer (Actigraph, model 7164) were worn
for ﬁve consecutive days (including at least one
weekend day) at the waist, above the right hipbone.
All participants were trained in placement and use of
the monitors and were asked to wear them during
waking hours, removing only for water-based activ-
ities and sleeping. Both the pedometer and acceler-
ometer are valid and reliable tools to objectively
measure PA [24, 25]. The pedometer, which had
a user viewable display, was used to count steps.
The accelerometer was used to measure accelerations
in the vertical plane and was set to measure activity
counts in an epoch time of 1 min. The accelerometer
had no display and activity data were reduced using
a Microsoft Excel-based Macro (MAHUffe Analyser
version 1.9.0.3) (www.mrc.epid.cam.ac.uk). Partici-
pantswithatleast10hoursofrecordedtimeandthree
complete days (including one weekend day) were
included in the analyses. Non-wearing time was de-
ﬁned as 60 min or more of consecutive zero counts.
The outcome variableswere time spent at activitiesof
different intensity [26]. Because more than 60% of
the participants did not accumulate any time in vig-
orous intensity PA, a single variable was constructed
by combining accumulated time in moderate-to-
vigorous physical activity (MVPA) [27]. Total PA
included light PA and MVPA. A cut-off of <100
counts min
1 deﬁned sedentary time [27].
An activity log was used to record date, the pe-
dometer steps taken and the type and duration of
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726non-walking activities [28]. Participants were asked
to complete the activity log at the end of each day
for ﬁve consecutive days. Following established
guidelines, participants were instructed to add 150
steps to their daily total for every minute engaged in
biking and/or swimming [28].
Health measurements
Body weight and height were measured wearing
light clothing and without shoes. Systolic and di-
astolic blood pressure was measured in seated po-
sition after 5 min of rest with an Omron 705IT.
Glycaemic control was measured by means of
HbA1c. The week after their home measurements
were completed, all participants went to the labora-
tory of the hospital where non-fasting blood sam-
ples were taken (as part of their routine analyses).
At baseline, participants completed a self-
administered background questionnaire with
demographic information, medication use and
diabetes-related questions.
Intervention
Both the CG and the IG received no speciﬁc advice
concerning diet or glycaemic control. They were
instructed to continue with the guidelines from their
dietician and endocrinologist.
The IG followed a 12-week lifestyle intervention
that consisted of ﬁve cognitive-behavioural group
sessions of 90 min. The ﬁrst three group meetings
weregivenevery2weeksinordertoprovide intense
guidance to the participants. The last two sessions
were delivered over an interval of 3 and 4 weeks
between sessions, so that participants could autono-
mously adopt the learned principles in their daily
life. Participants who were not able to participate
in one or more sessions received a written summary.
The cognitive-behavioural intervention was
based on cognitive-behavioural therapy [29], the
Diabetes Prevention Program [30], the FSP [31]
and Motivational Interviewing [32]. Within our
framework, social support, self-monitoring and
feedback (pedometer) are very important. The tax-
onomy of behaviour change techniques was also
taken into account [33]. Table I gives an overview
of the contents of the different sessions.
The group sessions started with a motivational
interviewing phase. After this phase, commitment
to a lifestyle change plan was strengthened: the
coaches together with the participants developed
an implementation plan in which the where, when
and how of the planned behaviour changes would
take place. The formulation of this plan was
intended to make it easier for the participants to
put the intended actions into practice.
Fig. 1. Study design.
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the IG received a pedometer and a pedometer diary
during the intervention as motivational tools. They
were asked to wear the pedometer and to record
their PA type and duration and number of steps at
the end of each day. In this way they could set their
own step goals in the context of their daily routine
[34]. The pedometer is proven to be a novel and
highly useful motivator, a direct source of feedback
and memory prompt and reminder to be physical
Table I. Content of the intervention
Session Session content Behavioural/cognitive and self-regulation strategies
Session 1 d Welcome
d Increasing knowledge of the
beneﬁts of PA
d Increasing awareness of the risk of
a sedentary lifestyle
d Information
d Consciousness raising
d Modelling and social
support
d Motivational readiness
d Mastery experience
Session 2 d Experiences with pedometers and goal
setting (skills)
d Monitoring sedentary activities/substituting
alternatives
d Increasing awareness of PA opportunities
d Time management (skills)
d Increasing self-efﬁcacy to set up an action
plan
d Listing personal beneﬁts and barriers of PA
and sedentary behaviour (changing
attitudes)
d Self-monitoring
d Activity reminders
d Mastery experience
d Reinforcement
d Modelling and social support
d Counter-conditioning
d Coaching in realistic and measurable goal setting
d Discussion action planDiscussion of beneﬁts of and barriers to
increase PA and decrease sedentary behaviour—decisional
balance
Session 3 d Increasing self-efﬁcacy to:
– overcome barriers,
– dealing with negative thoughts,
– change habits
d Recognizing and resolving ambivalence
d Discussion of problem-solving approach to address behaviours
d Cognitive restructuring
d Identifying discrepancies between behaviour and goals
d Reattribution trainingPlanning coping responses
d Counter-conditioning
Session 4 d Relapse prevention (skills)
d Increasing self-efﬁcacy to manage
high-risk situations and stress
d Increasing self-efﬁcacy to set up an action
plan
d Discussing about relapse prevention and problem-solving
barriers to PA
d Planning coping responses
d Counter-conditioning
d Coaching in realistic and measurable goal setting
d Feedback
Session 5 d Social cues
d Increasing self-efﬁcacy to set up
a long-term action plan and goal
achievement
d Identiﬁcation of supports for maintenance of health behaviour
changes
d Setting goals using support
d Enlisting support
d Reinforcement and feedback
d Coaching in realistic and measurable goal setting
Booster session d Social cues
d Increasing self-efﬁcacy to set up a
d long-term action plan and goal
d achievementRelapse prevention (skills)
d Reinforcement and feedback
d Coaching in realistic and measurable goal setting (using
support)
d Discussing about relapse prevention and problem-solving
future barriers to PA
d Planning coping responses
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progress and to encourage discussion in the group
sessions. Results of the baseline pedometer meas-
urements were used to motivate the patients to in-
crease their PA. At each session, participants and
coaches reviewed progress and set new goals to-
gether. At the end of the last session, the entire
process was reviewed, emphasizing participant
achievements and planning for continued PA en-
gagement without further support from the coaches.
After the intervention there was no further motiva-
tional contact until they were invited to a booster
session after 6 months. In this session, the progress
of the participants was discussed and the topics of
social support and relapse prevention were recalled.
The CG only received their usual care from their
endocrinologist and a single education session
about type 2 diabetes and PA, which was the same
as the ﬁrst session of the IG. They received only
information on the beneﬁts of PA and the risks of
sedentary behaviour and were not motivated to in-
crease their PA (received no pedometer during the
intervention).
Data treatment and statistical analyses
Data were analysed using SPSS15 for Windows
and were expressed as mean 6 SD, unless other-
wise stated. A P-value of 0.05 was considered
statistically signiﬁcant and a P-value of 0.1 a trend
towards signiﬁcance. Signiﬁcance levels of 0.1 and
0.001 are also added in the tables. Baseline differ-
ences between the IG and the CG were examined
using independent samples’ t-tests. Differences in
demographics between groups were evaluated by
v
2. A repeated-measures analysis of variance was
used to examine changes between groups in PA and
health measurements. Data were analysed using in-
tention-to-treat. Data of the participants who drop-
ped out were included in analyses; missing data for
Weeks 13 and 52 were substituted by their baseline
scores.
Based on intervention effects on number of steps
per day in previous research [14], a priori power
analysis was conducted. This analysis showed that
to power the study at 0.80 given the 0.05 level of
signiﬁcance, a sample size of minimum 20 partic-
ipants was needed for each sample separately.
Results
Sample characteristics and dropout
Baseline descriptive statistics for the 41 participants
are shown in Table II. The only difference between
both groups was perceived health status; more par-
ticipants in the CG perceived their health status as
weak (v
2 = 5.8, P = 0.02).
Dropout at T1 was 9.7% (two persons in each
group). At T2, the average dropout was 12.2% (one
more participant from the IG lost interest). Statistical
analysis showed no signiﬁcant differences in PA,
gender, body mass index (BMI) and age between
dropouts and those who completed the programme.
About 75% of the IG achieved adequate compli-
ance to the intervention (attending at least three of
the ﬁve sessions). There were no differences in out-
come variables between those with adequate com-
pliance and the remaining 25% of participants.
Effect of the interventions on patient
outcomes
Effect of the intervention on PA
There was a signiﬁcant interaction effect (P <0 . 0 5 )
in steps per day from T0 to T1 (Table III). The IG
increased their steps per day by 2502, in contrast
with the CG where there was almost no change (an
increase with 324 steps day
1). Between T1 and T2,
both groups decreased signiﬁcantly in steps per day
(P < 0.01) with a decrease of 1577 steps day
1 for
the IG and 1188 steps day
1 for the CG. When
comparing T0 and T2, there was a trend towards
a signiﬁcant interaction effect (P < 0.1): an increase
in steps per day for the IG (925 steps day
1)a n d
a decrease for the CG (864 steps day
1).
In Fig. 2, the difference in steps per day between
T0 and T1 is plotted for each individual participant.
All but three participants in the IG increased in
steps per day while in the CG about 50% of the
patients decreased. Only 9.5% of the CG increased
minimum 2000 steps day
1 after the intervention,
whereas 40% in the IG.
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ometer) revealed no interaction effects, only time
effects between T0 and T1 (P < 0.001). Both
groups signiﬁcantly increased in total PA: 37 min
day
1 for the CG and 46 min day
1 for the IG.
Between T1 and T2, an interaction effect was found
(P < 0.05): the IG decreased more in their total PA
than the CG.
Table II. Descriptive characteristics
Demographic
Total (N = 41) CG (N = 21) IG (N = 20) v
2
Gender 0.2
Male 28 15 13
Female 13 6 7
Age classes (years) 0.0
35–54 6 3 3
55–75 35 18 17
Civil state 0.0
Married 31 16 15
Single 10 5 5
Level of education 1.6
Low 12 8 4
High 29 13 16
Smoking 0.2
Non-smoker 7 3 4
Smoker 34 18 16
Duration diabetes (years) 0.0
1–5 16 8 8
>5 2 51 31 2
Health problems 3
None 21 8 13
Problems 20 13 7
Health status 5.8*
Good 17 5 12
Average or weak 22 15 7
PA Average 6 SD Average 6 SD Average 6 SD
Total CG IG
Pedometer
Steps per day 6135 6 3865 5214 6 3352 7099 6 4208 1.6
Accelerometer (min day
1)
Total PA 239 6 86 223 6 84 255 6 87 1.2
Light PA 208 6 80 200 6 81 216 6 80 0.6
MVPA 31 6 33 23 6 29 39 6 35 1.5
Sedentary behaviour 1195 6 91 1206 6 94 1183 6 90 0.8
Health measurements Average 6 SD Average 6 SD Average 6 SD T
Total CG IG
Weight (kg) 88.1 6 16.5 92.6 6 16.6 83.5615.5 1.8
BMI (kg m
2) 30.2 6 4.7 31.5 6 5.0 29.0 6 4.2 1.8
Age (years) 61.3 6 6.5 61.3 6 6.9 61.3 6 6.3 0.4
Diastolic blood pressure (mmHg) 83.5 6 10.4 82.6 6 11.0 84.4 6 9.9 0.6
Systolic blood pressure (mmHg) 151.8 6 23.2 148.6 6 21.0 155.1 6 25.3 0.9
HbA1c (%) 7.7 6 1.2 8.0 6 1.3 7.5 6 1.1 1.4
Total cholesterol (mg dl
1) 188.1 6 33.7 184.4 6 33.1 192.0 6 34.7 0.7
*P < 0.05.
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T0–T1–T2 T0–T1 T1–T2 T0–T2
Measurements T0 T1 T2 F time
3 group
F time F time
3 group
F time F time
3 group
F time F time
3 group
F time
Steps day
1 2.6(*) 5.9** 5.1* 8.5** 0.2 8.3** 2.8(*) 0.1
CG 5214 6 3352 5538 6 3877 4350 6 3214
IG 7099 6 4208 9601 6 5002 8024 6 5331
Total group 6135 6 3865 7520 6 4861 6142 6 4703
Min day
1 total active 1.4 9.8*** 0.2 17.4*** 3.3* 9.0** 1.2 0.9
CG 223 6 84 260 6 104 246 6 109
IG 255 6 87 301 6 106 253 6 99
Total group 239 6 86 281 6 106 250 6 103
Min day
1 light active 1.1 10.6*** 0.1 19.9*** 2.7(*) 7.1** 1.1 2.4(*)
CG 200 6 81 236 6 95 225 6 107
IG 216 6 80 256 6 93 221 6 89
Total group 208 6 80 246 6 94 223 6 97
Min day
1 MVPA 0.5 2.2(*) 0.4 1.0 1.3 4.1* 0.2 1.8(*)
CG 23 6 29 24 6 29 20 6 24
IG 39 6 35 44 6 38 32 6 34
Total group 31 6 33 35 6 35 26 6 30
Min day
1 inactive 4.6** 12.3*** 4.6* 20.9*** 9.9** 15.9*** 0.7 0.3
CG 1206 6 94 1180 6 104 1191 6 111
IG 1183 6 90 1111 6 118 1187 6 99
Total group 1195 6 91 1145 6 115 1189 6 104
Kg (mean 6 SD) 0.4 1.7 0.4 0.7 0.5 2.9* 0.2 3.4*
CG 92.6 6 16.6 92.6 6 15.8 94.9 6 18.7
IG 83.5 6 15.5 83.9 6 16.2 84.9 6 17.9
Total group 88.1 6 16.5 88.4 6 16.4 90.0 6 18.8
BMI (kg h
1) 1.0 3.0** 0.3 0.7 1.6 5.6* 0.1 3.0*
CG 31.5 6 5.0 31.5 6 4.7 32.6 6 5.2
IG 29.0 6 4.2 29.1 6 4.4 29.4 6 4.9
Total group 30.2 6 4.7 30.3 6 4.7 31.0 6 5.3
HbA1c (%) 1.0 3.4** 0.1 5.7* 2.0(*) 4.1* 0.8 1.6
CG 8.0 6 1.3 7.9 6 1.3 8.0 6 1.3
IG 7.5 6 1.1 7.3 6 1.1 7.9 6 1.2
Total group 7.7 6 1.2 7.6 6 1.2 7.9 6 1.2
Systolic blood pressure (mmHg) 0.3 1.5 0.2 1.6 0.5 0.4 0.1 2.8(*)
CG 148.6 6 21.0 143.9 6 20.4 144.2 6 22.6
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1Sedentary behaviour showed an interaction ef-
fect between T0 and T1 (P < 0.05) and T1 and T2
(P < 0.001). The IG decreased signiﬁcantly after 3
months, but on the long term they increased again
to their baseline levels. In the CG no signiﬁcant
changes were found.
Effect of the intervention on health measures
There were no signiﬁcant interaction effects on
BMI, weight, blood pressure, cholesterol and
HbA1c between T0, T1 and T2 (Table III).
TherewasasigniﬁcantdecreaseinHbA1cinboth
groups comparing T0 and T1 (P <0 . 0 5 )a n da g a i n
an increase at T2 to baseline levels (P <0 . 0 5 ) .
There was also a trend towards a signiﬁcant interac-
tion effect (P < 0.1) comparing the results at T1 and
at T2: the IG increased more in HbA1c than the CG.
Discussion
It was hypothesized that the IG would have a more
active lifestyle than the CG. This was conﬁrmed
for self-reported steps per day measured by the
pedometer and objectively measured sedentary
behaviour by the accelerometer but not for objec-
tively measured total PA.
The most obvious effects were found in steps
per day. Both groups had an increase after 3
months; however, this increase was much more
pronounced for the IG. Unfortunately, after 1 year
there was again a decrease for both groups. This
deterioration over time is typically observed in
intervention studies and is probably a result of
reduced contact [36]. However, when comparing
baseline and 1-year follow-up, the IG still showed
an increase of nearly 1000 steps day
1, whereas
the CG showed a decrease of almost the same
magnitude. The average increase in steps per
day of the IG was 2502. Forty percent of the par-
ticipants had an increase of minimum 2000 steps
day
1, which is very hopeful, as several interven-
tion studies have shown that an increase of 2000–
2500 steps day
1 can improve important health
outcomes [36]. After the intervention, average
steps per day of the IG was 9601, which is rather
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732high, considering the fact that we worked with el-
derly overweight type 2 diabetes patients. However,
this is lower than the average reported by Araiza
et al. [12] possibly because their participants were
given the directive to accumulate at least 10 000
steps day
1. In our study, however, the participants
could set their own goals, considering their own
baseline level.
The second aim of the study was to observe the
number of participants that changed favourably in
both groups. When we looked at each individual,
we found that all but three participants in the IG
increased their steps per day, while in the CG steps
per day decreased in half of the individuals. This
shows that averaging data induce loss of insight as
to individual outcome, and individual levels should
Fig. 2. Differences in steps per day.
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733also be considered when drawing conclusions from
an intervention.
These exploratory mean and individual level
ﬁndings on steps per day demonstrate the possible
utility of our six cognitive-behavioural sessions, in
combination with the use of a pedometer on the
short term, with a population known to have little
interest in, and a high dropout rate from structured
programmes [3].
The effects on sedentary behaviour were also
consistent with our hypothesis: sedentary behaviour
decreased by 72 min day
1 after 3 months for the
IG, compared with 26 min day
1for the CG. Earlier
studies showed that sedentary behaviour is posi-
tively associated with coronary heart disease risk
factors, obesity and development of the metabolic
syndrome [37]. Moreover, it has been suggested
that interventions should seek to decrease sedentary
behaviour [38]. Unfortunately, over the long term,
sedentary behaviour increased again for both
groups to baseline levels. This is in contrast with
the review of Dunn et al. [39], showing long-term
effects of lifestyle interventions on reducing seden-
tary behaviour.
However, the accelerometer data did not support
the intervention effects on PA. Both groups in-
creased in accelerometer-derived total PA after 3
months. The IG increased 11 min day
1 more than
the CG, but this result was too small to reveal a sta-
tistically signiﬁcant difference between both
groups. The discrepancy between effects on objec-
tively measured PA by the accelerometers and the
self-reportedstepsperdaymeasuredbyapedometer
is notable. However, it emerged from the group
sessions that more than 40% of the participants
chose the home exercise bike as PA tool and this
kind of PA is not measured by the accelerometer,
whereas the participants were instructed to add
steps for every minute they engaged in non-
ambulatory activities [28]. Secondly, it must be no-
ticed that the a priori power analyses for this study
were calculated only on steps per day and it seemed
that for accelerometer data our sample is underpow-
ered. So further investigation is needed with a larger
sample size and data where non-ambulatory activ-
ities are imputed.
In contrast to the hypothesis, there were no
effects of the intervention on most health measures.
There was a signiﬁcant short-term decrease only in
HbA1c in both groups, however, followed by a sig-
niﬁcant increase to baseline levels over the long
term. The lack of effect on health measures may
be logical as the behavioural effects were not en-
tirely maintained over the long term. Conversely, in
the Look-Ahead trial, important changes in health
measurements were observed, but this intervention
focused on diet and PA, whereas we only focused
on PA [16].
The present study has some limitations. First of
all, the sample was small. It was a pilot study with
some exploratory positive ﬁndings but it could be
possible that more signiﬁcant interaction effects
could be detected with a larger sample. A second
weakness is that the pedometer and the accelerom-
eter have limitations as research tools because of
their inability to provide information related to
non-ambulatory activity [40]. Thirdly, it must be
acknowledged that the trial is not blinded. Clearly
blinding to group allocation could not be main-
tained post-recruitment as with most behavioural
interventions. The psychologist who did the meas-
urements and lead the group sessions also did the
statistical analyses, however,in an anonymous way.
Fourthly, with the current design one could not
know if the intervention effects were due to only
the pedometer or the pedometer plus the group ses-
sions. It would have been better if a pedometer-only
group was used next to the CG and the IG (pedom-
eter plus group sessions). A last no cost or sustain-
ability assessment of the intervention was done.
The strengths of this study include (i) data on
both the short- and long-term, (ii) the use of
objective measurements of PA, (iii) the fact that
there was nearly no dropout in the data, (iv) the
detailed socio-demographic, medical and behaviou-
ral data obtained, (v) the compliance with the study
protocol and (vi) the well attended group meetings.
Conclusion
Thecognitive-behaviouralprogrammeandpedom-
eter succeeded in elevating the steps per day and
decreasingsedentarybehaviourinsedentarytype2
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are needed to understand how to maintain these
exploratory short-term ﬁndings and a larger sample
isneeded.A follow-upbyphone maybea promising
strategy to obtain long-lasting results [41]. From an-
other recently conducted intervention study in type 2
diabetes patients, it emerged that increases in PA
were mediated by coping with relapse, self-efﬁcacy
towards PA barriers and social norm, support and
modelling from family (K. De Greef, D. Van Dyck,
B. Deforche, J. Ruige, C. Tudor-Locke, J-M.
Kaufman, I. De Bourdeaudhuij, in preparation). It
might be important to target these identiﬁed media-
tors of PA change in future follow-up calls in type 2
diabetes patients. Moreover, the programme and the
pedometer were appealing to the target audience and
rathereasyto deliver compared with structured inter-
ventions. There were no effects on long-term health
parameters, so further research is needed to deter-
mine levels of PA needed to obtain important health
beneﬁts.
Practice implications
The present ﬁndings can be relevant to all people of
the multidisciplinary diabetes team. First of all, it
can be concluded that more attention must be given
to the topic of PA at the endocrinology department.
Because PA is one of the three cornerstones of di-
abetes management, patients need to receive more
information and motivation regarding PA than they
receive now. More speciﬁcally, it can be empha-
sized that a cognitive-behavioural approach and
a pedometer are promising to work with in this
population. However, continued support for a lon-
ger time than 3 months is probably necessary to
elicit long-term behavioural and health effects.
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